AbbVie

AbbVie: Hematology Clinical Account Specialist - San Diego

17 days ago   |   San Diego Biotechnology

AbbVie: Reporting into the Division Sales Manager, the Hematology Clinical Account Specialist will build and implement territory business plans that align wit San Diego, CA, US ...
Read more ...

AbbVie: Population Health Account Executive

21 days ago   |   San Diego Biotechnology

AbbVie: The Population Health Account Executive serves as executive liaison between AbbVie and key IDN/ Health Systems while also leading alignment and San Diego, CA, US ...
Read more ...

Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines

Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines

24 days ago   |   Xconomy

The FDA on Monday approved a pill from Allergan to treat migraine in adults. The treatment, ubrogepant , is part of a new class of migraine medicines designed to block...
Read more ...

Bio Roundup: Sarepta's Approval, Merck M&A, Drug Price Bill & More

Bio Roundup: Sarepta's Approval, Merck M&A, Drug Price Bill & More

1 month ago   |   Xconomy   |   2 articles

If you're keeping track, FDA drug approvals have been on a tear in the past month with several decisions coming well ahead of their targeted dates. And then there's Sarepta...
Read more ...

AbbVie: Account Executive- Oncology- San Diego

1 month ago   |   San Diego Biotechnology   |   2 articles

AbbVie: This individual will be responsible for developing and maintaining strategic business relationships with Oncology departments and practices consisting San Diego, CA, US ...
Read more ...

Amgen rejigs Bay Area presence with deal for new R&D facility

1 month ago   |   Fierce Biotech

Amgen has signed a lease on a 240,000-square-foot facility in South San Francisco, positioning it to join AbbVie in a new campus. The nine-story building will house Amgen's Bay...
Read more ...

Scripps Research, AbbVie Expand Drug Discovery Deal Beyond Cancer

Scripps Research, AbbVie Expand Drug Discovery Deal Beyond Cancer

1 month ago   |   Xconomy

The Scripps Research Institute and AbbVie have agreed to broaden an existing drug discovery agreement focused on cancer cell therapies to now encompass treatments for other...
Read more ...

Merck Makes a Big Blood Cancer Bet With $2.7B Deal for ArQule

Merck Makes a Big Blood Cancer Bet With $2.7B Deal for ArQule

1 month ago   |   Xconomy   |   2 articles

Merck is acquiring cancer drug developer ArQule for $2.7 billion , a cash deal that brings it a promising early-stage compound that could challenge a blockbuster leukemia drug...
Read more ...

Neurocrine Inks $50M Xenon Pharma Deal to Expand Into Epilepsy

Neurocrine Inks $50M Xenon Pharma Deal to Expand Into Epilepsy

1 month ago   |   Xconomy   |   2 articles

Neurocrine Biosciences is paying $30 million cash and taking a $20 million equity stake in Xenon Pharmaceuticals to license a clinical-stage epilepsy drug and collaborate on...
Read more ...

AbbVie: Hematology Clinical Account Specialist - San Diego

1 month ago   |   San Diego Biotechnology

AbbVie: Reporting into the Division Sales Manager, the Hematology Clinical Account Specialist will build and implement territory business plans that align wit San Diego, CA, US ...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Bio Roundup: EQRx's Ambitions, Nektar No Vote, New Frazier Fund & More

Bio Roundup: EQRx's Ambitions, Nektar No Vote, New Frazier Fund & More

Perhaps the most talked-about news at the JP Morgan Healthcare Conference this week was a new startup that launched with $200 million and an ambitious claim its first drug... Read more ...

Trending News on Crop Biotech in 2019

Trending News on Crop Biotech in 2019

We summarized the top 10 most trending Crop Biotech Update news shared on social media to give you a glimpse of crop biotech happenings in 2019. Read on and make sure you don't... Read more ...

Cancer Drug Developer BioNTech to Buy Neon Therapeutics in $67M Deal

Cancer Drug Developer BioNTech to Buy Neon Therapeutics in $67M Deal

Neon Therapeutics closed 2019 by curtailing its cancer vaccine programs and laying off 24 percent of its workforce, part of a corporate restructuring aimed at finding a new... Read more ...

Event Announcement: Xcelerating Life Sciences San Diego

Event Announcement: Xcelerating Life Sciences San Diego

We're excited to announce the first in Xconomy's new Xcelerating Life Sciences event series convening local communities of innovators, executives, rising pioneers... Read more ...

Mayo Clinic Joins $60M Financing for Biomedical Software Firm nference

Mayo Clinic Joins $60M Financing for Biomedical Software Firm nference

Startup nference has closed a $60 million Series B financing round to expand the use of its augmented intelligence platform in clinical research and drug development. Mayo... Read more ...

How Breast Cancer Reunited Six High School Friends

How Breast Cancer Reunited Six High School Friends

Four of the six of us from my high school inner circle have had breast cancer over the past two years. And that has me wondering. Did a shared environmental exposure, stamped... Read more ...

Stepping into their own

Stepping into their own

Two Bond Life Sciences Center researchers find their path in teaching and research Sarah Unruh and Vinit Shanbhag have both taken paths that have led them toward teaching... Read more ...

Emendo Biotherapeutics Nabs $61M for “Next-Generation CRISPR” R&D

Emendo Biotherapeutics Nabs $61M for “Next-Generation CRISPR” R&D

Emendo Biotherapeutics, a company aiming to apply CRISPR gene editing to a wider range of genetic diseases, has raised $61 million in financing. The Series B round was led by... Read more ...

103395 Biorepository Assistant

CANCER CENTER/ Solid Tumor Therapeutics Salary commensurate with qualifications and experienceFiling Deadline: Fri 1/31/2020... Read more ...

Quantitative visualization of subcellular lignocellulose revealing the...

As a renewable carbon source, biomass energy not only helps in resolving the management problems of lignocellulosic wastes, but also helps to alleviate the global climate... Read more ...